| 2026-08-21 | sam | Y-90 Glass Theraspheres | BOSTON SCIENTIFIC CORP | $350K | 0.4 |
| 2026-08-11 | sam | 6505--Alnylam Pharmaceuticals 09/01/2026 - 08/31/2031 | ALNYLAM PHARMACEUTICALS, | $387.8M | 1.0 |
| 2026-08-07 | sam | 6505--Abeona Therapeutics Inc. Effective: 08-15-2026 - 08-14 | ABEONA THERAPEUTICS INC. | $47.3M | 1.0 |
| 2026-07-30 | sam | 6505--Assertio Specialty Pharmaceuticals, LLC (PENDING PROPO | ASSERTIO SPECIALTY PHARMA | $14.0M | 0.9 |
| 2026-07-24 | sam | 6505--Budesonide/Formoterol INH | MYLAN PHARMACEUTICALS INC | $436.5M | 1.0 |
| 2026-07-23 | sam | 6505--Lab Supplies | Radiopharm | 5-Year Indefinite Deliver | CARDINAL HEALTH 414, LLC | $3.6M | 0.7 |
| 2026-07-13 | sam | Charleston CMOP-CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15M | D'S VENTURES, LLC | $61K | 0.2 |
| 2026-07-10 | sam | 6505--Alkermes, Inc August 01, 2026 - July 31, 2031 | ALKERMES, INC. | $1.68B | 1.0 |
| 2026-07-03 | sam | Chemistry, Manufacturing and Controls and Related Services f | SRI INTERNATIONAL | $49.9M | 1.0 |